[Pachydermia of the larynx--treatment with the aromatic retinoid (Ro 10-9359) (author's transl)].
Eight patients with pachydermia laryngis were treated with an aromatic retinoid (Ro 10-9359, Hoffmann La Roche, Basel, Switzerland). The management was successful in five cases. The sideeffects are minimal. The new drug seems to be a good completion in therapy of such diseases of the larynx.
D005050:Etretinate; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D007818:Laryngeal Diseases / Q000188:drug therapy*; D007822:Laryngeal Neoplasms / Q000601:surgery; D012075:Remission, Spontaneous; D014801:Vitamin A / Q000627:therapeutic use*; D014827:Vocal Cords / Q000601:surgery
D014801:Vitamin A; D005050:Etretinate
Behandlung von Larynxpachydermien mit aromatischem Retinoid (Ro 10-9359).